Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
about
Palladium-mediated dealkylation of N-propargyl-floxuridine as a bioorthogonal oxygen-independent prodrug strategyEfficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugsIn silico models of cancerBorononucleotides as substrates/binders for human NMP kinases: enzymatic and spectroscopic evaluation.Enantiomerically pure phosphonated carbocyclic 2'-oxa-3'-azanucleosides: synthesis and biological evaluation.Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.Novel anticancer polymeric conjugates of activated nucleoside analogues.Immobilization of Zidovudine Derivatives on the SBA-15 Mesoporous Silica and Evaluation of Their Cytotoxic Activity.Probing the ATP Site of GRP78 with Nucleotide Triphosphate Analogs.Prediction of therapeutic microRNA based on the human metabolic network.New nucleoside analogs for patients with hematological malignancies.Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies.Design of inhibitors of ODCase.Human metabolic network: reconstruction, simulation, and applications in systems biology.Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.Forodesine in the treatment of cutaneous T-cell lymphoma.Synthesis, cytotoxicity and cellular uptake studies of N3 functionalized Re(CO)3 thymidine complexes.Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism.The effects of forodesine in murine and human multiple myeloma cells.Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cellsC-5'-Triazolyl-2'-oxa-3'-aza-4'a-carbanucleosides: Synthesis and biological evaluation.
P2860
Q30629552-22ED6CBD-5FA1-4AD3-B669-08FFEA897FF1Q33997393-0E48D243-8D90-4207-98CF-13AA4AC6E5CBQ34137584-0A365144-3A25-4505-9B01-05457334DBF5Q34317110-6081F0F7-B4EB-4A94-B9F9-1696D26E4DE4Q34438680-0153A0A1-E1DD-4FBF-892B-0CCA039AEC87Q34567805-D6BA4456-90BD-4777-A686-C70F4477543FQ35436170-9208B058-0377-42F2-B66F-8A0DBA175CD2Q35571174-8C09358C-8C9C-4828-8D86-13F3D9C5A278Q36868425-759AF948-17CA-40F4-A234-0AF983B4ABDAQ37695446-4B9899FF-515A-4594-ADD9-AD6F5D6F9BD7Q37841589-4FBC4C0F-01CB-42BD-9C3F-7B3AC240AFC9Q38029728-531970B9-5638-41F4-9774-76CFFE40F4A2Q38182137-6DB27B8C-67E3-4F26-9B5F-06E43932C22AQ38222596-34BC5937-5EB9-4E8A-B7B7-E90F75FD0BB9Q38226402-35307828-DCAE-409B-BF65-4058F20B9E73Q39266443-D13F2AA0-A117-461A-85F8-597540133C5DQ39582589-DC6425C6-2C77-4B8B-BB29-2F9E85B4B2ABQ41846171-10F09473-8EF6-4A3E-ADEE-16C87A3B35AFQ41923743-83DEF558-0B7D-4B76-B27D-A2460BD00FCBQ42427923-07CAB47E-3D18-459A-9C93-6965D95FD1DAQ43188963-479ECB81-0F39-4F98-8B54-2B04FCA3D0CC
P2860
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
@en
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
@nl
type
label
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
@en
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
@nl
prefLabel
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
@en
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
@nl
P1476
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy
@en
P2093
C M Galmarini
F Popowycz
P304
P356
10.2174/092986708784221449
P577
2008-01-01T00:00:00Z